Track topics on Twitter Track topics that are important to you
New York-based private equity group Arsenal Capital Partners has signed a definitive agreement to acquire Cyalume Technologies Holdings for $45 million in cash.
Original Article: Arsenal Capital Buys Cyalume for $45 millionNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...